Biological psychiatry

publication venue for

Dimensional and Categorical Solutions to Parsing Depression Heterogeneity in a Large Single-Site Sample. 2024
Age-Accelerated Increase of White Matter Hyperintensity Volumes Is Exacerbated by Heavy Alcohol Use in People Living With HIV. 2023
Multimodal Data Integration Advances Longitudinal Prediction of the Naturalistic Course of Depression and Reveals a Multimodal Signature of Remission During 2-Year Follow-up.. 94. 2023
The Other Postpartum: Pregnancy Loss and Mental Illness. 2023
Excessive Protein Accumulation and Impaired Autophagy in the Hippocampus of Angelman Syndrome Modeled in Mice.. 94. 2022
Reduced Kv3.1 Activity in Dentate Gyrus Parvalbumin Cells Induces Vulnerability to Depression.. 88. 2020
Shared Transcriptional Signatures in Major Depressive Disorder and Mouse Chronic Stress Models.. 88. 2020
Diminished Fear Extinction in Adolescents Is Associated With an Altered Somatostatin Interneuron-Mediated Inhibition in the Infralimbic Cortex.. 86. 2019
The Psychiatric Risk Gene NT5C2 Regulates Adenosine Monophosphate-Activated Protein Kinase Signaling and Protein Translation in Human Neural Progenitor Cells.. 86. 2019
Quantifying the Effects of 16p11.2 Copy Number Variants on Brain Structure: A Multisite Genetic-First Study.. 84. 2019
Connective Tissue Growth Factor Is a Novel Prodepressant.. 84. 2018
Combined Analysis of Mifepristone for Psychotic Depression: Plasma Levels Associated With Clinical Response.. 84. 2018
Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.. 83. 2017
Mature Hippocampal Neurons Require LIS1 for Synaptic Integrity: Implications for Cognition.. 83. 2017
Altered GluA1 (Gria1) Function and Accumbal Synaptic Plasticity in the ClockΔ19 Model of Bipolar Mania.. 84. 2017
Dynamically Timed Stimulation of Corticolimbic Circuitry Activates a Stress-Compensatory Pathway.. 82. 2017
Attachment Insecurity and DNA Methylation in Risk for Postpartum Depression. 81. 2017
Psychosis Risk Candidate ZNF804A Localizes to Synapses and Regulates Neurite Formation and Dendritic Spine Structure.. 82. 2016
Extended Amygdala to Ventral Tegmental Area Corticotropin-Releasing Factor Circuit Controls Binge Ethanol Intake.. 81. 2016
Vasopressin Boosts Placebo Analgesic Effects in Women: A Randomized Trial.. 79. 2015
A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression.. 78. 2014
A genome-wide association study of autism using the Simons Simplex Collection: Does reducing phenotypic heterogeneity in autism increase genetic homogeneity?. 77. 2014
Neurobiological signatures of anxiety and depression in resting-state functional magnetic resonance imaging.. 77. 2014
The cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population.. 77. 2014
Cell-type specific expression of p11 controls cocaine reward.. 76. 2014
Default mode network mechanisms of transcranial magnetic stimulation in depression.. 76. 2014
Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy.. 75. 2013
Brain organization underlying superior mathematical abilities in children with autism.. 75. 2013
Adjusting head circumference for covariates in autism: clinical correlates of a highly heritable continuous trait.. 74. 2013
Shared and distinct intrinsic functional network centrality in autism and attention-deficit/hyperactivity disorder.. 74. 2013
Default mode network in childhood autism: posteromedial cortex heterogeneity and relationship with social deficits.. 74. 2013
Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-specific expression of anxiety-like behavior in female mice.. 72. 2012
R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.. 72. 2012
Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling.. 71. 2012
Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.. 71. 2011
Aberrant striatal functional connectivity in children with autism.. 69. 2010
Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.. 68. 2010
YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.. 68. 2010
Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.. 69. 2010
Vascular function in older adults with depressive disorder.. 68. 2010
Association of a polyadenylation polymorphism in the serotonin transporter and panic disorder.. 67. 2009
Amygdala enlargement in toddlers with autism related to severity of social and communication impairments.. 66. 2009
Serotonin modulation of cerebral glucose metabolism in depressed older adults.. 66. 2009
Autonomic activation during sleep in posttraumatic stress disorder and panic: a mattress actigraphic study.. 66. 2009
Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.. 65. 2008
Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation.. 65. 2008
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease.. 64. 2008
Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses.. 65. 2008
Biological substrates of emotional reactivity and regulation in adolescence during an emotional go-nogo task.. 63. 2008
Augmented D1 dopamine receptor signaling and immediate-early gene induction in adult striatum after prenatal cocaine.. 63. 2008
Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder.. 63. 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.. 62. 2007
Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.. 63. 2007
Preliminary evidence that hippocampal volumes in monkeys predict stress levels of adrenocorticotropic hormone.. 62. 2007
Prenatal exposure to cocaine increases the rewarding potency of cocaine and selective dopaminergic agonists in adult mice.. 63. 2007
Using the autism diagnostic interview--revised to increase phenotypic homogeneity in genetic studies of autism.. 61. 2007
Fibroblast growth factor receptor-1 is required for long-term potentiation, memory consolidation, and neurogenesis.. 62. 2007
Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus.. 62. 2007
Salivary cortisol and psychopathology in children bereaved by the september 11, 2001 terror attacks.. 61. 2006
White-matter integrity predicts stroop performance in patients with geriatric depression.. 61. 2006
A delusion assessment scale for psychotic major depression: Reliability, validity, and utility.. 60. 2006
Saliva cortisol and response to dexamethasone in children of depressed parents.. 60. 2006
Preadolescent methylphenidate versus cocaine treatment differ in the expression of cocaine-induced locomotor sensitization during adolescence and adulthood.. 60. 2006
Activation in ventral prefrontal cortex is sensitive to genetic vulnerability for attention-deficit hyperactivity disorder.. 60. 2006
The neuropsychological profile of psychotic major depression and its relation to cortisol.. 60. 2006
Cortisol circadian rhythm alterations in psychotic major depression.. 60. 2006
Sex differences in diencephalon serotonin transporter availability in major depression.. 59. 2005
Executive dysfunction and the course of geriatric depression.. 58. 2005
Mild early life stress enhances prefrontal-dependent response inhibition in monkeys.. 57. 2005
Contributions of amygdala and striatal activity in emotion regulation.. 57. 2005
Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats.. 57. 2005
Changes in cerebrospinal fluid neurochemistry during pregnancy.. 56. 2004
Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.. 56. 2004
Frontal lobe gray matter density decreases in bipolar I disorder.. 55. 2004
Opiate addicts lack error-dependent activation of rostral anterior cingulate.. 55. 2004
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.. 54. 2003
S-adenosyl-L-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects.. 54. 2003
A magnetic resonance spectroscopic imaging study of adult nonhuman primates exposed to early-life stressors.. 54. 2003
The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patients.. 54. 2003
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.. 54. 2003
Differential patterns of striatal activation in young children with and without ADHD.. 53. 2003
Reversed cerebellar asymmetry in men with first-episode schizophrenia.. 53. 2003
An open label trial of C-1073 (mifepristone) for psychotic major depression.. 52. 2002
Antidepressant-like effects of cytidine in the forced swim test in rats.. 51. 2002
Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression.. 51. 2002
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.. 51. 2002
Variable foraging demand rearing: sustained elevations in cisternal cerebrospinal fluid corticotropin-releasing factor concentrations in adult primates.. 50. 2001
Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus.. 49. 2001
Amygdala response to facial expressions in children and adults.. 49. 2001
CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype.. 48. 2000
A pilot study of amygdala volumes in pediatric generalized anxiety disorder.. 48. 2000
Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients.. 46. 1999
A.E. Bennett Research Award. Developmental traumatology. Part II: Brain development.. 45. 1999
Brain computed tomography in geriatric manic disorder.. 45. 1999
Normal CSF oxytocin and NPY levels in OCD.. 45. 1999
Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression.. 45. 1999
Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid in man.. 45. 1999
Peripheral serotonin measures in prepubertal psychiatric inpatients and normal children: associations with suicidal behavior and its risk factors.. 44. 1998
Subsensitivity of adenylyl cyclase-coupled receptors on mononuclear leukocytes from drug-free inpatients with a major depressive episode.. 42. 1997
Medical comorbidity in elderly psychiatric inpatients.. 41. 1997
Sleep in the wake of complicated grief symptoms: an exploratory study.. 41. 1997
Association of the APOE epsilon 4 allele with clinical subtypes of late life depression.. 40. 1996
Effects of the PCP analog dizocilpine on sensory gating: potential relevance to clinical subtypes of schizophrenia.. 40. 1996
Behavioral effects of naloxone infusion in obsessive-compulsive disorder.. 40. 1996
Comparison of obsessions and compulsions in patients with anorexia nervosa and obsessive compulsive disorder.. 39. 1996
Age at onset of geriatric depression and sensorineural hearing deficits.. 38. 1995
Psychiatric status after human fetal mesencephalic tissue transplantation in Parkinson's disease.. 38. 1995
Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable.. 37. 1995
Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man.. 36. 1994
The relationship of platelet 5-HT2 receptor indices to major depressive disorder, personality traits, and suicidal behavior.. 35. 1994
Pain perception in self-injurious borderline patients: naloxone effects.. 35. 1994
Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression.. 34. 1993
Geriatric depression: age of onset and dementia.. 34. 1993
State specificity of DST abnormalities in geriatric depression.. 34. 1993
Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.. 33. 1993
Caffeine potentiation of taste in panic-disorder patients.. 33. 1993
Pain perception in self-injurious patients with borderline personality disorder.. 32. 1992
Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology.. 32. 1992
Brain computed tomography findings in geriatric depression and primary degenerative dementia.. 31. 1992
Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder.. 31. 1992
Suicidal behavior and hypothalamic-pituitary-adrenocortical axis indices in child psychiatric inpatients.. 29. 1991
Natural killer cell activity in adolescents with major depression.. 29. 1991
Effects of age and gender on CNS serotonergic responsivity in normal adults.. 27. 1990
Natural killer cell activity in depressive illness: preliminary report.. 26. 1989
Psychopathology and plasma cortisol responses to dexamethasone in prepubertal psychiatric inpatients.. 26. 1989
Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients.. 26. 1989
Sensation-Seeking Scale scores in treated geriatric depressives and controls.. 26. 1989
Positive and negative symptoms in schizophrenia and the Dexamethasone Suppression Test.. 25. 1989
Immune function in mania.. 24. 1988
Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase.. 23. 1988
Cornell Scale for Depression in Dementia.. 23. 1988
Plasma 10-hydroxynortriptyline and renal function in elderly depressives.. 22. 1987
Diminished mitogen-induced calcium uptake by lymphocytes from Alzheimer patients.. 22. 1987
Delusional depression, family history, and DST response: a pilot study.. 21. 1986
Periventricular lucencies in the CT scans of aged and demented patients.. 21. 1986
Biochemistry and suicidal behavior in depressed patients.. 21. 1986
Dexamethasone suppression test in geriatric depression.. 19. 1984
Unilateral electroconvulsive therapy: an open clinical comparison of two electrode placements.. 19. 1984
Effects of eight-hour naloxone infusions on human subjects.. 18. 1983
Rubidium uptake into red blood cells compared with that of lithium.. 17. 1982
Clinical application of the probenecid test for measurement of monoamine turnover in the CNS.. 16. 1981
A primate analogue of amphetamine-induced behaviors in humans.. 16. 1981
Characteristics of the uptake of lithium isotopes into erythrocytes.. 14. 1979
Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.. 13. 1978
N5,10-methylenetetrahydrofolate reductase activity in autopsied brain parts of chronic schizophrenics and controls and in vitro tryptoline formation.. 13. 1978
Body fluid lithium measurements: severity of illness and prediction of outcome.. 13. 1978
Difficulties in comparing catecholamine-related enzymes from the brains of schizophrenics and controls.. 13. 1978
Assortative mating in primary affective disorder.. 11. 1976
Biochemical approaches to the study of synaptic function.. 2. 1970
Epinephrine formation and metabolism in mammalian brain.. 1. 1969
Decomposing Heterogeneity in Autism Spectrum Disorder Through Neurosubtyping.. 87. 2020
Parsing the Hippocampus in Depression: Chronic Stress, Hippocampal Volume, and Major Depressive Disorder.. 85. 2019
Endocannabinoids and Stress Resilience: Is Deficiency Sufficient to Promote Vulnerability?. 79. 2016
From Faces to Feelings in Early Child Development.. 78. 2015
The impact of stimulants on cognition and the brain in attention-deficit/hyperactivity disorder: what does age have to do with it?. 76. 2014
Fear and anxiety from principle to practice: implications for when to treat youth with anxiety disorders.. 75. 2013
N-acetylcysteine for the treatment of glutathione deficiency and oxidative stress in schizophrenia.. 71. 2012
Gamma-melanotropin and beta-endorphin after dexamethasone.. 25. 1989
Probenecid monoamine test [correction].. 24. 1988
Solubility of lithium salts in organic solvents.. 20. 1985
CSF probenecid and biogenic amines.. 19. 1984
Candidate Epigenetic Biomarker of Cognitive Trajectory: The Chicken or the Egg? 2022
Social Stress-Induced Behavioral Adaptations in Females: A Focus on Midline Thalamus Crh Neurons. 2021
Translating Schizophrenia Population Genetics Findings to Neurobiological Mechanisms: The Case of KALRN-9. 2018
Metabolism and Memory: Obesity, Diabetes, and Dementia. 2017
The vascular depression hypothesis: 10 years later.. 60. 2006
Lateralization in the frontal lobes: searching the right (and left) way.. 38. 1995
An Adolescent Sensitive Period for Threat Responding: Impacts of Stress and Sex. 2020
Common Polymorphisms in the Age of Research Domain Criteria (RDoC): Integration and Translation. 2015
Atypical prefrontal connectivity in attention-deficit/hyperactivity disorder: pathway to disease or pathological end point? 2011
Late-life depression: a model for medical classification. 2005
Comorbidity of depression with other medical diseases in the elderly. 2002
Comorbidity of late life depression: an opportunity for research on mechanisms and treatment. 2002
Developing novel treatments for mood disorders: accelerating discovery. 2002
Overcoming barriers to reducing the burden of affective disorders. 2002
Psychosocial risk factors for depressive disorders in late life. 2002
Diagnosis of childhood and adolescent suicidal behavior: unmet needs for suicide prevention. 2001
Sex Differences in Neurodegeneration: The Role of the Immune System in Humans. 2021
Nonhuman Primate Models to Explore Mechanisms Underlying Early-Life Temperamental Anxiety. 2020
Causes and Consequences of Diagnostic Heterogeneity in Depression: Paths to Discovering Novel Biological Depression Subtypes. 2020
Genetics of Resilience: Gene-by-Environment Interaction Studies as a Tool to Dissect Mechanisms of Resilience. 2019
Vascular depression: An archetypal neuropsychiatric disorder. 2006

VIVO Weill Cornell Medical College

Biological psychiatry Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)